Britain First In World To Approve Merck’s COVID Pill

Reuters reports:

Britain on Thursday became the first country in the world to approve a potentially game-changing COVID-19 antiviral oral pill jointly developed by Merck and Ridgeback Biotherapeutics, in a boost to the fight against the pandemic.

The Medicines and Healthcare products Regulatory Agency (MHRA) recommended that the drug, molnupiravir, be used as soon as possible following a positive COVID-19 test and within five days of the onset of symptoms.

Read the full article.